October 2009 
Volume 39  Number 10
Pages 16 - 17
  PDF Version Available!


As a result of data linking opioid pain medications and fatal overdoses, the FDA is taking action to reduce the risk. The agency is requiring manufacturers of products containing propoxyphene, such as Darvon and Darvocet, to emphasize the potential for overdose in a black box warning on the product's packaging. Manufacturers will also be required to provide a Medication Guide for patients that stresses the importance of following directions carefully when taking the drug.

In addition, the FDA is requiring a new safety study to assess unanswered questions about the effects of higher doses of propoxyphene on the heart. They're also working with the Centers for Medicare and Medicaid Services and the Veterans Health Administration to study how often older patients are prescribed drugs containing propoxyphene instead of other pain medications, and the ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events